CoChat

LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson’s disease

Open access

The DOI matches its Crossref record; 80 of the 84 references it cites were found in a registry or an index.

Abstract

Mutations of LRRK2, encoding leucine-rich repeat kinase 2 (LRRK2), are the leading cause of autosomal dominant Parkinson's disease (PD). The most frequent of these mutations, G2019S substitution, increases kinase activity, but it remains unclear how it causes PD. Recent studies suggest that LRRK2 modulates mitochondrial homeostasis. Mitochondrial dysfunction plays a key role in the pathogenesis of autosomal recessive PD forms linked to PARK2 and PINK1, encoding the cytosolic E3 ubiquitin-protein ligase Parkin and the mitochondrial kinase PINK1, which jointly regulate mitophagy. We explored the role of LRRK2 and its kinase activity in PINK1/Parkin-dependent mitophagy. LRRK2 increased mitochondrial aggregation and attenuated mitochondrial clearance in cells coexpressing Parkin and exposed to the protonophore carbonylcyanide m-chlorophenylhydrazone. Förster resonance energy transfer imaging microscopy showed that LRRK2 impaired the interactions between Parkin and Drp1 and their mitochondrial targets early in mitophagy. The inhibition of LRRK2 kinase activity by a 'kinase-dead' LRRK2 mutation or with a pharmacological inhibitor (LRRK2-IN-1) restored these interactions. The monitoring of mitophagy in human primary fibroblasts with the novel dual-fluorescence mtRosella reporter and a new hypothermic shock paradigm revealed similar defects in PD patients with the G2019S LRRK2 substitution or PARK2 mutations relative to healthy subjects. This defect was restored by LRRK2-IN-1 treatment in LRRK2 patients only. Our results suggest that PD forms due to LRRK2 and PARK2 mutations involve pathogenic mechanisms converging on PINK1/Parkin-dependent mitophagy.

Overview

Integrity signals

Registry

Crossref · 10.1093/hmg/ddz004

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 163

Metadata

Authors
Bonello, F., Hassoun, S.-M., Mouton-Liger, F., Shin, Y. S., Muscat, A., Tesson, C., Lesage, S., Beart, P. M., Brice, A., Krupp, J., Corvol, J.-C., & Corti, O.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
  • The University of Melbourne (AU)
  • Ipsen (France) (FR)
Corresponding author
Corti, Olga
Venue
Human Molecular Genetics
Published
2019-01-09
Volume
28
Issue
10
Pages
1645-1660
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2910996474
Cited by
163
References
84
Citations by year
2026: 19 · 2025: 20 · 2024: 14 · 2023: 17 · 2022: 28 · 2021: 29 · 2020: 22 · 2019: 14
FWCI
15.73
Type
journal article
Language
en
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Association France Parkinson
  • Innovative Medicines Initiative (115568)
  • European Union Seventh Framework Programme (FP7/2007–2013)
  • European Federation of Pharmaceutical Industries and Associations (ANR-10-IAIHU-06)
  • Association Nationale Recherche Technologie and Association France Parkinson
  • International Union of Biochemistry and Molecular Biology
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
LRRK2, Parkinson's disease, PINK1, Parkin, mitophagy, LRRK2 kinase activity, LRRK2 G2019S mutation, PARK2 mutations, mitochondrial homeostasis, Drp1, mitochondrial aggregation, mitochondrial dysfunction
MeSH terms
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, PTEN-Induced Putative Kinase, Adult, Aged, Benzodiazepinones, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Female, Fibroblasts, Humans, Male, Middle Aged, Mitochondria, Mutation, Parkinson Disease, Phosphorylation, Protein Kinases, Pyrimidines, Fluorescence Resonance Energy Transfer, Ubiquitin-Protein Ligases, Primary Cell Culture, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.